The main objective of setting standards for the Nigerian Poultry industry is to put in motion a procedure for providing wholesome Animal products for human consumption. This procedure sets maximal standards to minimize the potential food safety hazards associated with livestock production and processing. The policy recognizes the main elements in the production process and outlines the food safety objectives for the different Activities along the value chain.

The purpose of this procedure is to describe the processes of management system certification (MSC) to meet the requirement of ISO 17021 – 1. This procedure applies to all management system certification services offered by the SON MSC. It covers SON MSC certification processes from initial application to continuing surveillance after certification has been achieved.

The 2017 appropriation act highlights the various Expenditures for the ministry of water resources

This scheme is a Public-Private Partnership intervention that enables the Federal Government of Nigeria to leverage private sector funding for the construction or refurbishment of eligible road infrastructure projects in Nigeria. It focuses on the development of eligible road infrastructure projects efficiently and effectively that creates value for money through private sector discipline and also guarantees participants in the scheme timely and full recovery of funds provided for the construction or refurbishment of eligible road infrastructure projects in the manner prescribed in this executive order.

The Nigerian Nuclear Regulatory Authority (NNRA), established by the Nuclear Safety and Radiation Protection Act 19 of 1995 (the Act) is charged with the sole responsibility for nuclear safety and radiological protection regulation in Nigeria (Article 4 of the Act.) In this regard, the NNRA is empowered to license practices involving handling, transportation and storage of radioactive sources. This document provides the requirement for accreditation for land transportation of radioactive sources.

The National Youth Policy recognises the broader policy context in which it has been formulated and shall operate. It is guided largely by other national policy initiatives and it is also reflective of international programmes and conventions. This policy is based on a commitment to extensive consultations, respect for diversity of interests and opinion, input and consensus from the grassroots and local communities in the spirit of national ownership. It affirms and upholds the fundamental human rights of all youth, including their rights to fundamental freedoms, development opportunities and full participation in the democratic and governance processes, as well as in community and civic decision-making and development agenda.

This is an Act to restrict the use of foreign vessels in domestic coastal trade to promote the development of indigenous tonnage and to establish a cabotage vessel financing fund and for related matters.

This guideline document seeks to facilitate the establishment and development of national capacities to implement, manage, monitor, establish adequate information systems, develop expert human resources in cabotage administration and enforcement and generally promote the efficient operation of the cabotage regime. These objectives would be achieved by the development of guidelines, standards, codes of practice, and monitoring capabilities for the operators, enforcement agencies, and financial institutions, establishment of a comprehensive and up-to-date database, infrastructure for information exchanges upon which cabotage administration and enforcement can be processed, promotion of regular review of administrative and policy measures on cabotage and enforcement can be processed and establishment and strengthening of national and institutional cabotage implementation mechanisms.

This document highlights the guidelines on the registration for a national carrier, shipping companies/agents and cabotage operators

The 2017 appropriation act highlighting the various Expenditures for the ministry of science and technology

The National Agency for Food and Drug Administration and Control has the responsibility of ensuring that herbal remedies/dietary supplements made in Nigeria products placed on the Nigerian market for use meet the requirements for quality, safety and efficacy throughout the lifecycle of the product. The procedure for registration of herbal remedies/dietary supplements made in Nigeria outlines the process to be followed and the technical requirements to be met before a product can be placed on the Nigerian market. It is intended to provide guidance on the technical and other general data requirements when submitting an application for the renewal of a product license for herbal remedies/dietary supplements made in Nigeria.

These guidelines are for the interest of the general public and in particular, manufacturers’ importers, distributors of controlled drugs and precursor chemicals in Nigeria. The document provides guidance on the application for a permit to import, inspection and timeline for the processes.

These guidelines are for the public and in particular persons intending for warehouse inspection. Warehouse inspection is a prerequisite to the issuance of a chemical import permit or listing certificate (authorization to market chemicals). Therefore, this document prescribes the minimum safety standard for chemical handling, documentation, personnel requirement, facility and timeline for warehouse inspection.

This document is an adaptation of the World Health Organization (WHO) guidelines on registration requirements to establish interchangeability. It provides appropriate In vivo and In vitro requirements to assure interchangeability of the generic product without compromising the safety, quality and efficacy of the pharmaceutical product and is generally applicable to orally administered generic products as well as to certain non-orally administered pharmaceutical products (e.g. transdermal delivery systems and certain parenteral, rectal and nasal pharmaceutical products.

This guidance document is technically and structurally inspired by the World Health Organisation’s variation guideline on the details of the various categories of variations to the terms of marketing authorizations for medicinal products for human use and veterinary medicinal products. The objectives of these guidelines are to assist applicants with the classification of changes made to the quality part of a registered Finished Pharmaceutical Product (FPP) and provide guidance on the technical and other general data requirements to support changes to the quality attributes of the Active Pharmaceutical Ingredient (API) or FPP.

This document guides application for a license to possess and use an X-ray unit, equipment specifications for enclosed exposure facilities and training requirements.

Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of humans. It provides unified standards for the conduct of clinical data in Nigeria. The guidelines describe the responsibilities and expectations of all participants in the conduct of clinical trials, including investigators, monitors, sponsors and ethics committees.

These cosmetic Good Manufacturing Practice (GMP) guidelines are for the manufacture, storage and shipment of cosmetic products. The primary objective of the guidelines is to ensure that products are consistently manufactured in conformance with quality standards. It is concerned with all aspects of production and quality control.

Good manufacturing practice (GMP) is that part of quality assurance that ensures that pharmaceutical products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by their marketing authorizations. These guidelines apply to pharmaceutical, biological, and veterinary products and they are intended to help all stakeholders comply with the provisions of the National Agency for Food and Drug Administration and Control (NAFDAC) good manufacturing Practice Regulations for pharmaceutical products.

Cold chain management is a specialized area of Biopharmaceutical products management that begins when a Biopharmaceutical product is manufactured, stored and moves through the distribution chain until it gets to the end-user at the time of administration. It is required that the product be held and distributed in a controlled environment. It is necessary to have adequate control of all steps and procedures involved both in manufacturing and quality control, storage and distribution, to ensure that product quality is maintained. Therefore, this document was designed to guide importers and owners of storage facilities for medicines that require cold chain management. This is to provide stakeholders with the relevant regulatory requirements needed to maintain the compliance status of their operational activities.